Cargando…
Scintigraphic tracking of (99m)Technetium-labelled equine peripheral blood-derived mesenchymal stem cells after intravenous, intramuscular, and subcutaneous injection in healthy dogs
BACKGROUND: Mesenchymal stem cell treatments in dogs have been investigated as a potential innovative alternative to current conventional therapies for a variety of conditions. So far, the precise mode of action of the MSCs has yet to be determined. The aim of this study was to gain more insights in...
Autores principales: | Beerts, Charlotte, Brondeel, Carlien, Pauwelyn, Glenn, Depuydt, Eva, Tack, Liesa, Duchateau, Luc, Xu, Yangfeng, Saunders, Jimmy H., Peremans, Kathelijne, Spaas, Jan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278733/ https://www.ncbi.nlm.nih.gov/pubmed/34256833 http://dx.doi.org/10.1186/s13287-021-02457-9 |
Ejemplares similares
-
Homing of radiolabelled xenogeneic equine peripheral blood-derived MSCs towards a joint lesion in a dog
por: Beerts, Charlotte, et al.
Publicado: (2022) -
Review: Mesenchymal Stem Cell Therapy in Canine Osteoarthritis Research: “Experientia Docet” (Experience Will Teach Us)
por: Brondeel, Carlien, et al.
Publicado: (2021) -
Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing
por: Beerts, Charlotte, et al.
Publicado: (2023) -
Technetium-99m MDP bone scintigraphic findings of hypercalcemia in accelerated phase of chronic myelogenous leukemia.
por: Kwak, H. S., et al.
Publicado: (2000) -
A Feasibility Study on the Use of Equine Chondrogenic Induced Mesenchymal Stem Cells as a Treatment for Natural Occurring Osteoarthritis in Dogs
por: Daems, Robert, et al.
Publicado: (2019)